US FDA's Generics Program Reaches 'Steady State' Milestone
OGD Director Uhl says program is now in balance between the number of submissions and agency review actions.
![FDAEntrance_1200x675](https://insights.citeline.com/resizer/v2/HTMRSXAMEZKWVJRN7BWZV3AH4I.jpg?smart=true&auth=17f21f1fac36cb7748229dc90d9302b2d94d72377f7dfeec74363ac998171687&width=700&height=394)
OGD Director Uhl says program is now in balance between the number of submissions and agency review actions.